| Reference range | Group A | Group B | Group C |
---|---|---|---|---|
Sex | ||||
 Male (n) |  | 2 | 7 | 6 |
 Female (n) |  | 3 | 3 | 4 |
Age (years) | Â | 4.4(0.5) | 10.3(1.8) | 9.1(3.7) |
Body weight (kg) | Â | 12.2(1.9)a | 36.4(7.4) | 38.6(11.8) |
Osteoarthritis radiographic score (no unit) | 0–9 | Not applicable | 6.7(3.3) | 5.8(2.9) |
Affected joints | ||||
• Bilateral hips |  | n = 3 | n = 3 | |
• Stifle (right) |  | n = 2 | n = 3 | |
• Bilateral hips and shoulders |  | n = 1 | n = 3 | |
• Bilateral hips and elbow |  | n = 2 | n = 1 | |
• Bilateral elbows |  | n = 1 |  | |
• Shoulder (right) |  | n = 1 |  | |
Duration of clinical signs evolution (months) | As reported by the owners | Â | 4.1(1.8) | 5.6(2.4) |
Red blood cell count (M/mm3) | 5.5–8.5 | 6.8(0.7) | 7.2(1.1) | 7.5(0.6) |
Hematocrit (%) | 37–54 | 50.9(4.6) | 44.6(7.8) | 49.4(6.4) |
Hemoglobin concentration (g/dL) | 12–18 | 15.9(1.3) | 16.4(2.9) | 15.8(1.9) |
Mean corpuscular volume (μ3) | 60–77 | 75.2(0.8) | 67.6(1.0) | 71.2(3.4) |
Mean corpuscular hemoglobin concentration (g/dL) | 31–36 | 31.3(0.2) | 34.3(1.8) | 32.6(3.1) |
Leucocyte count (m/mm3) | 6–17 | 5.5(0.6) | 7.2(3.2) | 9.8(2.6) |
Platelet count (m/mm3) | 160–525 | 450.8(95.2) | 448(122.2) | 384.8(118.4) |
Blood urea nitrogen (mEq/L) | 2.1–9.7 | 4.2(1.1) | 5.8(1.4) | 4.8(0.9) |
Creatinine (μmol/L) | 42–135 | 62(10.8) | 93.3(14.4) | 82.5(13.2) |
Alkaline phosphatase (UI/L) | 0–200 | 61.0(15.1) | 53.6(28.8) | 92.4(86.2) |
Alanine aminotransferase (UI/L) | 0–130 | 52.2(38.4) | 46.2(28.8) | 38.2(16.7) |
Platelet aggregation time (seconds) | 0–213 | 133.6(17.7) | 178.2(32.4) | 168.7(38.5) |
Gastrointestinal endoscopic score (no unit) | 0–50 | 2.4(1.8) | 1.6(1.5) | 1.1(1.6) |
Glomerular filtration rate (mL/min/m2) | 55–117.1 | 97.2(7.15) | 87.9(14.1) | 94.6(12.9) |